Medical News

RSS

New global goals in the areas of nutrition, environment and workplace practices

PepsiCo, the world's second-largest food and beverage company, today announced new global goals in the areas of nutrition, the environment, and workplace practices at its investor conference here at the Legends Suite Club in Yankee Stadium.

22 Mar 2010

NYSE Amex grants Interleukin Genetics extension for regaining compliance

Interleukin Genetics, Inc. announced today that the Corporate Compliance Staff of the NYSE Amex LLC has granted the Company an extension to meet the Exchange's continued listing standards and become compliant. The Company will remain listed up to June 23, 2010, subject to periodic review by the Exchange staff during the extension period of progress towards the Company's plan to regain compliance.

22 Mar 2010

First patient dosed in NCI-sponsored Phase 1/2 trial of belinostat

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology and hematology, and TopoTarget A/S, today announced that the first patient has been dosed in a National Cancer Institute -sponsored Phase 1/2 trial of belinostat in combination with cisplatin, doxorubicin and cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies.

22 Mar 2010

University of Maryland professor honored with the 2010 Stockholm Water Prize

Dr. Rita Colwell, distinguished Professor from the University of Maryland and John Hopkins University's Bloomberg School of Public Health in the United States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's pioneering research on the prevention of waterborne infectious diseases has helped protect the health and lives of millions.

22 Mar 2010

USAID, Coca-Cola announce additional joint investment of $12.7M in global partnership

Today, the U.S. Agency for International Development and The Coca-Cola Company announce an additional joint investment of US$12.7 million in their global partnership, the Water and Development Alliance.

22 Mar 2010

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

Medical Facilities Corporation, today reported its financial results for the three and twelve-month periods ended December 31, 2009. All amounts are expressed in U.S. dollars unless indicated otherwise.

22 Mar 2010

LCOA announces official launch of new website for Cielo Latino

The Latino Commission on AIDS today announced the official launch of www.latinoaids.org/cielo, its website for Cielo Latino, the largest annual national fundraiser for the Latino community in its fight against HIV/AIDS.

22 Mar 2010

Acorda Therapeutics submits applications to extend patent protection for AMPYRA to USPTO

Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.

22 Mar 2010

First Edition: March 22, 2010

Today's headlines detail yesterday's historic House vote on health reform while also looking forward to how action might play out in the Senate, how the legislative package impacts the current political dynamic and what its effects will be on consumers and stakeholders.

22 Mar 2010

Dow Jones reports on side effects of Labopharm's once-daily version of Trazodone, stock falls by 5%

After Canadian specialty pharmaceutical company Labopharm received FDA approval for its once-daily version of antidepressant Trazodone, Dow Jones Newswires reported that it will be difficult to convince prescribers to switch from less expensive generic versions. Dow Jones found that when compared, the side effects of Labopharm's drug fare no better than the generic versions that dominate the market.

22 Mar 2010

Holly Robinson Peete partners with MHAIA on PSA inspiring adults to model good eating habits

Actress and philanthropist Holly Robinson Peete has partnered with The Mexican Hass Avocado Importers Association on a public service announcement inspiring adults to "lead by example" by making smart food choices their children can emulate. MHAIA's goal is to help reduce the incidence of childhood obesity by encouraging families to eat more fruits and vegetables.

22 Mar 2010

Surgeon General to outline priorities at PCPCC Stakeholder's Summit

Surgeon General Regina Benjamin, MD, knows first-hand the connection doctors and patients need in order to address tough chronic health threats. Benjamin will discuss her priorities as Surgeon General in a keynote address at the Stakeholder's Summit of the Patient-Centered Primary Care Collaborative (PCPCC) at 10 a.m. on March 30 in Washington, DC.

22 Mar 2010

Investment report on Gentium from InvestorSoup.com

InvestorSoup.com announces an investment report featuring Gentium SpA. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

22 Mar 2010

Opportunity to repair America's broken health care system

We commend Speaker Nancy Pelosi and the House leadership for their efforts that made this vote possible, and we commend members of the House of Representatives who stood up to insurance company interests and voted yes, for real reform.

22 Mar 2010

AngioDynamics welcomes book on “Irreversible Electroporation”

AngioDynamics today welcomed the publication of the book “Irreversible Electroporation,” published by Springer Berlin Heidelberg.

22 Mar 2010

Health insurance reform legislation: Speaker Nancy Pelosi's remarks on the House floor

Speaker Nancy Pelosi spoke on the House floor tonight in support of historic health insurance reform legislation. The House passed the Senate version of health insurance reform legislation by a vote of 219 to 212. That bill now goes to the President for his signature into law. A second bill, to improve the Senate bill, passed by a vote of 220 to 211 and goes to the Senate. Below are the Speaker's remarks.

22 Mar 2010

InterAction joins other NGOs to solve world's growing WASH crisis

InterAction joins other U.S.-based non-governmental organizations (NGOs) in calling for the United States government to commit available resources to solve the world's growing water, sanitation and hygiene crisis. World Water Day provides us with an opportunity to focus attention on the fact that millions of people in the developing world lack access to safe drinking water and basic sanitation.

22 Mar 2010

StockPreacher.com releases investment report on A.P. Pharma

StockPreacher.com announces an investment report featuring A.P. Pharma Inc. (Nasdaq:APPA). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

22 Mar 2010

Psychologists study the effect of online ostracism on children

Research by psychologists at the University of Kent has revealed that online ostracism is a threat to children's self-esteem.

22 Mar 2010

Medical News

New global goals in the areas of nutrition, environment and workplace practices

NYSE Amex grants Interleukin Genetics extension for regaining compliance

First patient dosed in NCI-sponsored Phase 1/2 trial of belinostat

University of Maryland professor honored with the 2010 Stockholm Water Prize

USAID, Coca-Cola announce additional joint investment of $12.7M in global partnership

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Medical Facilities' service revenue increases from $199.4M in 2008 to $207.4M in 2009

LCOA announces official launch of new website for Cielo Latino

Acorda Therapeutics submits applications to extend patent protection for AMPYRA to USPTO

First Edition: March 22, 2010

Dow Jones reports on side effects of Labopharm's once-daily version of Trazodone, stock falls by 5%

Holly Robinson Peete partners with MHAIA on PSA inspiring adults to model good eating habits

Surgeon General to outline priorities at PCPCC Stakeholder's Summit

Investment report on Gentium from InvestorSoup.com

Opportunity to repair America's broken health care system

AngioDynamics welcomes book on “Irreversible Electroporation”

Health insurance reform legislation: Speaker Nancy Pelosi's remarks on the House floor

InterAction joins other NGOs to solve world's growing WASH crisis

StockPreacher.com releases investment report on A.P. Pharma

Psychologists study the effect of online ostracism on children

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News